Join to View Full Profile
111 S 11th StSte 4240Philadelphia, PA 19107
Phone+1 215-955-8874
Fax+1 215-955-2340
Dr. Dessain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
Yale School of MedicineClass of 1994
Certifications & Licensure
PA State Medical License 2002 - 2026
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsMemory loss and aberrant neurogenesis in mice exposed to patient anti-N-methyl-d-aspartate receptor antibodies.Olga Taraschenko, Howard S Fox, Priscilla Heliso, Fetweh Al-Saleem, Scott Dessain
Experimental Neurology. 2024-08-01 - MyD88-mediated signaling is critical for the generation of seizure responses and cognitive impairment in a model of anti-N-methyl-D-aspartate receptor encephalitis.Olga Taraschenko, Howard S Fox, Ember Eldridge, Priscilla Heliso, Fetweh Al-Saleem
Epilepsia. 2024-05-01 - 8 citationsRecombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2.Kathrin Göritzer, Elisabetta Groppelli, Clemens Grünwald-Gruber, Rudolf Figl, Fengfeng Ni
Molecular Therapy. 2024-03-06
Press Mentions
InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine CharacterizationJuly 1st, 2021
Multiplexed, Microscale, Microarray-Based Serological Assay for Antibodies Against All Human-Relevant CoronavirusesFebruary 25th, 2021- Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19July 28th, 2020
- Join now to see all
Grant Support
- Human Monoclonal Antibodies That Bind Botulinum ToxinsNational Institute Of Allergy And Infectious Diseases2007–2012
- Human Monoclonal Antibodies That Bind Botulinum ToxinsNational Institute Of Allergy And Infectious Diseases2006–2007
- Progression Of Chronic Myelogenous LeukemiaNational Heart, Lung, And Blood Institute2002–2004
- Progression Of Chronic Myelogenous LeukemiaNational Heart, Lung, And Blood Institute2000–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
